Modification of P3-cap. From tert-butylurea (compound 1) to

Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor

P3-P4 ureas and reverse carbamates as potent HCV NS3 protease

Modification of P3-cap. From tert-butylurea (compound 1) to

INHIBITORS OF AKT ACTIVITY - Patent 2303269

Discovery and Structure−Activity Relationship of P1−P3 Ketoamide

Boceprevir in complex with NS3/4A. (A) The shallow and solvent

Modification of P3-cap. From tert-butylurea (compound 1) to

Hepatitis C: The Story of a Long Journey through First, Second

US7750003B2 - Compounds-943 - Google Patents